This is an FDA-approved device from HealthWatchSystems, Inc., of Alpharetta, GA. According to the official website, the watch-like device has been shown to predict ovulation 5 days in advance for females who ovulate regularly. OV-Watch works through a biochem sensor that detects changes of chloride ions in sweat.
Researchers in the late 50s and early 60s noted that numerous salts (chloride, sodium, potassium) in a woman’s sweat fluctuated in relation to the menstrual cycle. Chloride levels are low at the start of the menstrual cycle and peak three times during the cycle (see graph below). Using a patented biosensor, OV-Watch detects a baseline chloride ion level for each woman and then accurately predicts ovulation based on the timing of the first peak. The OV-Watch detects the chloride surge 3 days prior to the estrogen surge, 4 days prior to the LH surge and 5 days prior to ovulation, making it an earlier predictor of ovulation than any other chemical surge during the month. During the clinical trials for FDA approval with Dr. Arthur Haney at Duke University, approximately 3 out of 4 women received the full 5 day notice of ovulation while only 1 in 6 women were given more than 12 to 24 hours notice with urine tests or LH kits. For women trying to conceive, knowing the days before ovulation not only lowers the stress level for her and her partner , but it increases her chances of getting pregnant.
The device is currently undergoing phase IV trials over at Emory University to “evaluate the effectiveness of the OV-Watch to predict ovulation while women are taking clomiphene citrate.”